Institute for Public Health, National Institutes of Health, Ministry of Health Malaysia, Shah Alam, Selangor, Malaysia.
Sultanah Aminah Hospital, Ministry of Health Malaysia, Johor Bahru, Johor, Malaysia.
BMC Nephrol. 2020 Aug 14;21(1):344. doi: 10.1186/s12882-020-01966-8.
The prevalence of chronic kidney disease (CKD) in Malaysia was 9.07% in 2011. We aim to determine the current CKD prevalence in Malaysia and its associated risk factors.
A population-based study was conducted on a total of 890 respondents who were representative of the adult population in Malaysia, i.e., aged ≥18 years old. Respondents were randomly selected using a stratified cluster method. The estimated glomerular filtration rate (eGFR) was estimated from calibrated serum creatinine using the CKD-EPI equation. CKD was defined as eGFR < 60 ml/min/1.73m or the presence of persistent albuminuria if eGFR ≥60 ml/min/1.73m.
Our study shows that the prevalence of CKD in Malaysia was 15.48% (95% CI: 12.30, 19.31) in 2018, an increase compared to the year 2011 when the prevalence of CKD was 9.07%. An estimated 3.85% had stage 1 CKD, 4.82% had stage 2 CKD, and 6.48% had stage 3 CKD, while 0.33% had stage 4-5 CKD. Hypertension (aOR 3.72), diabetes mellitus (aOR 3.32), increasing BMI (aOR 1.06), and increasing age (aOR 1.06) were significantly associated with CKD.
Our study has shown that CKD has become one of the leading public health issues in Malaysia. Thus, there is an urgent need to screen for CKD and prevent its progression, associated morbidity, and mortality at the national level.
2011 年马来西亚慢性肾脏病(CKD)的患病率为 9.07%。本研究旨在确定马来西亚目前 CKD 的患病率及其相关危险因素。
本研究为一项基于人群的研究,共纳入 890 名受访者,他们代表了马来西亚的成年人口,年龄≥18 岁。采用分层聚类法随机选择受访者。使用 CKD-EPI 方程,根据校正后的血清肌酐估算肾小球滤过率(eGFR)。CKD 的定义为 eGFR<60ml/min/1.73m 或 eGFR≥60ml/min/1.73m 时存在持续白蛋白尿。
本研究显示,2018 年马来西亚 CKD 的患病率为 15.48%(95%CI:12.30,19.31),高于 2011 年的 9.07%。估计有 3.85%的患者患有 1 期 CKD,4.82%的患者患有 2 期 CKD,6.48%的患者患有 3 期 CKD,而 0.33%的患者患有 4-5 期 CKD。高血压(aOR 3.72)、糖尿病(aOR 3.32)、BMI 增加(aOR 1.06)和年龄增加(aOR 1.06)与 CKD 显著相关。
本研究表明 CKD 已成为马来西亚主要的公共卫生问题之一。因此,迫切需要在全国范围内筛查 CKD 并预防其进展、相关发病率和死亡率。